2026
Publications
Publications
Browse recent publications with filters for title, author, journal, and year.
2026
mRNA vaccination targeting AML1::ETO fusion gene eliminates leukemia cells via activating T cells
2026
Valosin-Containing Protein Contributes to Plexiform Neurofibroma Formation and Represents a Novel Therapeutic Target
2026
Trisomy 8 alters chromatin conformations and activates Y chromosome genes in stem cells to drive a pre-leukemic state
2026
Insights and modulation of RNA polymerase-dependent R-loop and dsRNA in Fanconi anemia hematopoietic stem cells
2026
Driver mutation-defined molecular landscapes of essential thrombocythemia
2026
Luspatercept ameliorates disease phenotype and complications in the Townes mouse model of sickle cell disease
2025
The RNA N(6)-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signaling
2025
Aberrant splicing of CHEK1 is a driver of megakaryocytic dysplasia in U2AF1(S34F) mutant myelodysplastic neoplasms
2025
Mitophagy's impacts on cancer and neurodegenerative diseases: implications for future therapies
2025
Super-resolution imaging informed scRNA sequencing analysis reveals the critical role of GDF15 in rejuvenating aged hematopoietic stem cells
2025
Integrated Computational and Functional Screening Identifies G9a Inhibitors for SETD2-mutant Leukemia
2025
Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory
2025
Age-Dependent Bi-Phasic Dynamics of Ly49(+)CD8(+) Regulatory T Cell Population
2025
CD133-Guided RNA Nanoparticle Delivery of FTO siRNA Impairs Leukemia Resistance to Tyrosine Kinase Inhibitor Therapy
2025
Sexual dimorphism in the mouse bone marrow niche regulates hematopoietic engraftment via sex-specific Kdm5c/Cxcl12 signaling
2025
Loss of Cpt1a results in elevated glucose-fueled mitochondrial oxidative phosphorylation and defective hematopoietic stem cells
2024
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
2024
The Laws of Attraction: Chemokines as Critical Mediators in Cancer Progression and Immunotherapy Response in Bladder Cancer
2024
Long-term benefits of hematopoietic stem cell-based macrophage/microglia delivery of GDNF to the CNS in a mouse model of Parkinson's disease
2024
Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromes
2024
Into the storm: the imbalance in the yin-yang immune response as the commonality of cytokine storm syndromes
2023
Food for thought (and CML survival)
2023
Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs
2023